COLIZZI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 314
EU - Europa 25
Totale 339
Nazione #
US - Stati Uniti d'America 279
CA - Canada 32
IT - Italia 19
PA - Panama 3
IE - Irlanda 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
DE - Germania 1
Totale 339
Città #
Princeton 84
Toronto 32
Andover 30
Chandler 27
Ashburn 7
Treia 4
Udine 4
Redmond 3
Trieste 3
Ponte Lambro 2
Rome 2
Kyjov 1
Menlo Park 1
Monfalcone 1
Ruda 1
Wilmington 1
Totale 203
Nome #
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 14
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 13
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 11
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 11
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 11
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 11
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 11
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 10
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 10
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 10
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 10
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 9
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 9
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 9
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 9
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 9
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 9
Cannabis and psychosis: What do we know and what should we do? 9
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 9
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 9
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 9
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 8
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 8
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 8
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: A case-control study 8
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 8
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 8
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 8
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 8
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 7
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 7
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 7
Evaluating psychobiological and mental distress in transsexualism before and after cross-sex hormonal treatment: Lesson learned from three longitudinal studies 7
To treat or not to treat: Puberty suppression in childhood-onset gender dysphoria 7
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 7
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 7
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 7
Cannabis use and the development of tolerance: a systematic review of human evidence 7
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 7
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 7
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 7
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 7
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 7
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 6
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 6
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 6
Meet the Editorial Board Member 6
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 6
Cannabis: Neuropsychiatry and its effects on brain and behavior 6
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 6
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 6
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 6
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 6
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 6
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: An online parent survey 5
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 5
Hormonal Treatment Reduces Psychobiological Distress in Gender Identity Disorder, Independently of the Attachment Style 5
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 5
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition 5
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 5
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 5
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 5
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 5
Substance use, medication adherence and outcome one year following a first episode of psychosis 5
Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real? 5
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 5
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with tourette syndrome: Preliminary evidence from a case series 5
Prevention and early intervention in youth mental health: Is it time for a multidisciplinary and trans-diagnostic model for care? 5
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 5
Lo stigma nella salute mentale 5
Differential gene expression analysis in blood of first episode psychosis patients 5
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 5
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry 5
Epigenetic mediation of akt1 rs1130233′s effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 5
The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review 5
Gender-Oriented Mental Health Prevention: A Reappraisal 5
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 5
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 5
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 5
Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior 5
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure 5
Descriptive psychopathology of the acute effects of intravenous delta-9-tetrahydrocannabinol administration in humans 5
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 5
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 4
Neurodevelopmental Disorders and Psychosocial Issues Later in Life 2
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 2
Totale 593
Categoria #
all - tutte 2714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0000 00 92175 0041155
2022/2023130 8713273 00 00 0000
Totale 593